BridgeMD
New treatment option for Myocardial Infarction with Nonobstructive Coronary Arteries
Official title Stockholm Myocardial Infarction with Nonobstructive Coronaries Study 3
ClinicalTrials.gov ID: NCT05426408
What this study is testing
- What it's testing
- The present pilot study will investigate the prevalence of CMD in an unselected cohort of patients with the working diagnosis MINOCA and to study if the diagnostic yield can be improved by adding adenosine to the CMR investigation. Patient will be their own controls.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 79
You may be able to join if
- a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
- age 35-80 years
- reading and writing proficiency in Swedish
You likely can't join if
- Claustrofobia
- Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III)
- Asthma or severe chronic obstructive lung disease
- eGFR \< 30 ml/min
- spontaneous coronary artery dissection
- acute pulmonary embolism
See the full eligibility criteria
- a suspected diagnosis of MINOCA or takotsubo syndrome with coronary angiography without diameter stenosis ≥50%
- age 35-80 years
- reading and writing proficiency in Swedish
- Claustrofobia
- Arrythmia and/or pacemaker (atrial fibrillation and AV-block I- III)
- Asthma or severe chronic obstructive lung disease
- eGFR \< 30 ml/min
- spontaneous coronary artery dissection
- acute pulmonary embolism
- acute myocardial infarction type 2
- cardiomyopathy other than takotsubo syndrome
- a previous myocardial infarction due to CAD
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 79 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.